Capital Asset Advisory Services LLC Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Capital Asset Advisory Services LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 9.8% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 7,125 shares of the healthcare conglomerate’s stock after buying an additional 638 shares during the quarter. Capital Asset Advisory Services LLC’s holdings in UnitedHealth Group were worth $3,247,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Bell Investment Advisors Inc raised its position in shares of UnitedHealth Group by 4.8% during the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 24 shares in the last quarter. Harbor Investment Advisory LLC raised its position in shares of UnitedHealth Group by 3.2% during the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after acquiring an additional 1,129 shares in the last quarter. Verdence Capital Advisors LLC raised its position in shares of UnitedHealth Group by 2.1% during the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock worth $8,919,000 after acquiring an additional 342 shares in the last quarter. Austin Private Wealth LLC increased its position in UnitedHealth Group by 9.8% during the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after buying an additional 111 shares during the period. Finally, Bellecapital International Ltd. increased its position in UnitedHealth Group by 1.4% during the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after buying an additional 193 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 4.8 %

UNH opened at $509.58 on Friday. The business’s fifty day moving average is $498.34 and its two-hundred day moving average is $502.27. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market cap of $469.01 billion, a price-to-earnings ratio of 31.15, a PEG ratio of 1.41 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter last year, the company earned $6.26 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analyst Ratings Changes

Several research analysts have commented on the company. Morgan Stanley cut their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Robert W. Baird assumed coverage on UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price target on the stock. JPMorgan Chase & Co. lifted their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, TD Cowen dropped their target price on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.